[The effect of thymalin on lipid metabolism and the clinical course of ischemic heart disease].
The effect of the thymus polypeptide factor-thymidin on the lipid spectrum of the blood, thymic factor content in the blood and clinical course of the disease were studied in 156 patients with exertion stenocardia (II-IV functional class). Results indicate that patients with exertion stenocardia show with advance of the disease a reduction of the blood thymic factor and 85.6% develop hyperlipidemia. Complex treatment with inclusion of thymalin resulted in an increase of the thymic factor, normalization of the lipid metabolism increase of the contractile function of the myocardium and, thus, increases the treatment efficacy.
Shustval'
N F
NF
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D000787:Angina Pectoris / Q000097:blood / Q000188:drug therapy; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood*; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood / Q000188:drug therapy*; D005082:Physical Exertion; D013951:Thymus Hormones / Q000627:therapeutic use*
D000276:Adjuvants, Immunologic; D008055:Lipids; D013951:Thymus Hormones; C032805:thymalin
Vliianie timalina na lipidnyĭ obmen i klinicheskoe techenie ishemicheskoĭ bolezni serdtsa.